Max Smock
Stock Analyst at William Blair
(1.28)
# 3,954
Out of 5,182 analysts
18
Total ratings
36.36%
Success rate
-9.91%
Average return
Main Sectors:
Stocks Rated by Max Smock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SHC Sotera Health Company | Initiates: Outperform | n/a | $14.87 | - | 1 | Dec 18, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Outperform | n/a | $4.07 | - | 1 | May 21, 2025 | |
| MEDP Medpace Holdings | Downgrades: Market Perform | n/a | $496.00 | - | 4 | Apr 22, 2025 | |
| FTRE Fortrea Holdings | Reiterates: Market Perform | n/a | $9.01 | - | 5 | Mar 4, 2025 | |
| CRL Charles River Laboratories International | Downgrades: Market Perform | n/a | $168.22 | - | 2 | Jan 22, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | n/a | $109.62 | - | 1 | Jan 14, 2025 | |
| SLP Simulations Plus | Reiterates: Outperform | n/a | $12.46 | - | 4 | Nov 6, 2024 |
Sotera Health Company
Dec 18, 2025
Initiates: Outperform
Price Target: n/a
Current: $14.87
Upside: -
Lifecore Biomedical
May 21, 2025
Initiates: Outperform
Price Target: n/a
Current: $4.07
Upside: -
Medpace Holdings
Apr 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $496.00
Upside: -
Fortrea Holdings
Mar 4, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.01
Upside: -
Charles River Laboratories International
Jan 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $168.22
Upside: -
ICON Public Limited Company
Jan 14, 2025
Reiterates: Outperform
Price Target: n/a
Current: $109.62
Upside: -
Simulations Plus
Nov 6, 2024
Reiterates: Outperform
Price Target: n/a
Current: $12.46
Upside: -